These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 19129426)

  • 1. An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice.
    Lu SC; Xu J; Chinookoswong N; Liu S; Steavenson S; Gegg C; Brankow D; Lindberg R; Véniant M; Gu W
    Mol Pharmacol; 2009 Apr; 75(4):901-7. PubMed ID: 19129426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
    Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
    Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats.
    Salomé N; Haage D; Perrissoud D; Moulin A; Demange L; Egecioglu E; Fehrentz JA; Martinez J; Dickson SL
    Eur J Pharmacol; 2009 Jun; 612(1-3):167-73. PubMed ID: 19356720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the ghrelin receptor to regulate food intake.
    Depoortere I
    Regul Pept; 2009 Aug; 156(1-3):13-23. PubMed ID: 19362579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
    Falls HD; Dayton BD; Fry DG; Ogiela CA; Schaefer VG; Brodjian S; Reilly RM; Collins CA; Kaszubska W
    J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin and the short- and long-term regulation of appetite and body weight.
    Cummings DE
    Physiol Behav; 2006 Aug; 89(1):71-84. PubMed ID: 16859720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents.
    Gourcerol G; Coskun T; Craft LS; Mayer JP; Heiman ML; Wang L; Million M; St-Pierre DH; Taché Y
    Obesity (Silver Spring); 2007 Nov; 15(11):2643-52. PubMed ID: 18070755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trp3, Arg5]-ghrelin(1-5) stimulates growth hormone secretion and food intake via growth hormone secretagogue (GHS) receptor.
    Ohinata K; Kobayashi K; Yoshikawa M
    Peptides; 2006 Jul; 27(7):1632-7. PubMed ID: 16530883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
    Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
    J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ghrelin/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake.
    Hassouna R; Zizzari P; Tolle V
    J Neuroendocrinol; 2010 Jul; 22(7):793-804. PubMed ID: 20456603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ghrelin administration on decreased growth hormone status in obese animals.
    Iwakura H; Akamizu T; Ariyasu H; Irako T; Hosoda K; Nakao K; Kangawa K
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E819-25. PubMed ID: 17595213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ghrelin on food intake and energy homeostasis.
    De Vriese C; Delporte C
    Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):615-9. PubMed ID: 17693746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. At the cutting edge: ghrelin gene products in food intake and gut motility.
    Chen CY; Fujimiya M; Asakawa A; Chang FY; Cheng JT; Lee SD; Inui A
    Neuroendocrinology; 2009; 89(1):9-17. PubMed ID: 18931475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice.
    Long RT; Zeng WS; Chen LY; Guo J; Lin YZ; Huang QS; Luo SQ
    Int J Obes (Lond); 2010 Apr; 34(4):712-9. PubMed ID: 20065960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin and the growth hormone secretagogue receptor in growth and development.
    Chanoine JP; De Waele K; Walia P
    Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S48-52. PubMed ID: 19363508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin.
    Asakawa A; Inui A; Fujimiya M; Sakamaki R; Shinfuku N; Ueta Y; Meguid MM; Kasuga M
    Gut; 2005 Jan; 54(1):18-24. PubMed ID: 15591499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of food intake by acyl and des-acyl ghrelins in the goldfish.
    Matsuda K; Miura T; Kaiya H; Maruyama K; Shimakura S; Uchiyama M; Kangawa K; Shioda S
    Peptides; 2006 Sep; 27(9):2321-5. PubMed ID: 16687192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure.
    Pfluger PT; Kirchner H; Günnel S; Schrott B; Perez-Tilve D; Fu S; Benoit SC; Horvath T; Joost HG; Wortley KE; Sleeman MW; Tschöp MH
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G610-8. PubMed ID: 18048479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
    Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.